These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3428460)

  • 1. [Decreased blood histamine levels in malignant melanoma].
    Kölmel KF
    Dermatol Monatsschr; 1987; 173(10):577-84. PubMed ID: 3428460
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients.
    Weinlich G; Murr C; Richardsen L; Winkler C; Fuchs D
    Dermatology; 2007; 214(1):8-14. PubMed ID: 17191041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic significance of serum hemopexin in patients with malignant melanoma].
    Popović S; Roguljić A; Nola P; Maricić Z
    Lijec Vjesn; 1975; 97(4):241-4. PubMed ID: 1177660
    [No Abstract]   [Full Text] [Related]  

  • 4. Parathyroid hormone-related protein in patients with malignant melanoma.
    Elias AN; Pandian MR; Jacowatz J
    Arch Dermatol; 1992 Feb; 128(2):278-9. PubMed ID: 1739318
    [No Abstract]   [Full Text] [Related]  

  • 5. [Quantitative investigations of the pregnancy associated alpha 2-glycoprotein (PAG) in malignant melanoma (author's transl)].
    Göring HD; Bundschuh G; Schubert H; Lukowsky A; Knopf B; Lübbe D; Wohlrab W
    Dermatol Monatsschr; 1981 Apr; 167(4):217-23. PubMed ID: 7262378
    [No Abstract]   [Full Text] [Related]  

  • 6. High serum level of 5-S-cysteinyldopa in chronic renal failure does not always indicate melanoma progression.
    Asada Y; Arakawa S; Fujiwara S; Sato F; Kaneda K
    Br J Dermatol; 2004 Aug; 151(2):515-6. PubMed ID: 15327571
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acidic erythrograms and the copper content in the erythrocytes of patients with solid malignant tumors].
    Sokolova II; Ratsa MP; Kochetkova MK
    Lab Delo; 1982; (7):391-4. PubMed ID: 6181297
    [No Abstract]   [Full Text] [Related]  

  • 8. [Polyamine and histamine contents in the blood of pigmented, depigmented and melanoma bearing Lipizzaner horses].
    Desser H; Niebauer GW; Gebhart W
    Zentralbl Veterinarmed A; 1980 Feb; 27(1):45-53. PubMed ID: 6774520
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy.
    Wimmer I; Meyer JC; Seifert B; Dummer R; Flace A; Burg G
    Cancer Res; 1997 Nov; 57(22):5073-6. PubMed ID: 9371505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of serum analyses of S-100 protein beta in malignant melanoma.
    Hansson LO; von Schoultz E; Djureen E; Hansson J; Nilsson B; Ringborg U
    Anticancer Res; 1997; 17(4B):3071-3. PubMed ID: 9329604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques.
    Caputo E; Lombardi ML; Luongo V; Moharram R; Tornatore P; Pirozzi G; Guardiola J; Martin BM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):59-66. PubMed ID: 15797521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
    Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
    Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin.
    Alberg AJ; Gordon GB; Genkinger JM; Hoffman SC; Selvin E; Comstock GW; Helzlsouer KJ
    Anticancer Res; 2001; 21(6A):4051-4. PubMed ID: 11911290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous measurement of circulating intercellular adhesion molecule-1 and serum copper zinc superoxide dismutase activity in patients with malignant melanoma.
    Wollina U; Karte K; Olbertz K; Hipler UC
    Oncol Rep; 1998; 5(2):473-6. PubMed ID: 9468582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100 serum level: a tumour marker for metastatic melanoma.
    Bottoni U; Izzo P; Richetta A; Mannooranparampil TJ; Devirgiliis V; Del Giudice M; Reale MG; Frati L; Calvieri S
    Melanoma Res; 2003 Aug; 13(4):427-9. PubMed ID: 12883371
    [No Abstract]   [Full Text] [Related]  

  • 16. [Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study].
    Lakomý R'; Greplová K; Pilný R; Budinská E; Valík D; Poprach A; Nemecek R; Vyzula R
    Klin Onkol; 2009; 22(5):228-32. PubMed ID: 19886361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unexpected inverse correlation between soluble epidermal growth factor receptor and interleukin-6 in metastatic malignant melanoma patients.
    Mouawad R; Soubrane C; Rixe O; Khayat D; Spano JP
    Melanoma Res; 2006 Aug; 16(4):335-40. PubMed ID: 16845329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.
    Ekborn A; Hansson J; Ehrsson H; Eksborg S; Wallin I; Wagenius G; Laurell G
    Laryngoscope; 2004 Sep; 114(9):1660-7. PubMed ID: 15475801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma.
    Helfrich I; Edler L; Sucker A; Thomas M; Christian S; Schadendorf D; Augustin HG
    Clin Cancer Res; 2009 Feb; 15(4):1384-92. PubMed ID: 19228739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIA, a novel serum marker for progression of malignant melanoma.
    Bosserhoff AK; Lederer M; Kaufmann M; Hein R; Stolz W; Apfel R; Bogdahn U; Buettner R
    Anticancer Res; 1999; 19(4A):2691-3. PubMed ID: 10470221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.